diphenhydramine hydrochloride has been researched along with benzonatate in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (27.27) | 18.7374 |
| 1990's | 2 (9.09) | 18.2507 |
| 2000's | 1 (4.55) | 29.6817 |
| 2010's | 10 (45.45) | 24.3611 |
| 2020's | 3 (13.64) | 2.80 |
| Authors | Studies |
|---|---|
| Cohan, JA; Conradi, SE; Long, C; Lukash, L; Manning, TJ; Ziminski, KR | 1 |
| Sant'Ambrogio, FB; Sant'Ambrogio, G | 1 |
| Oberg, B; Thorén, P | 1 |
| Doona, M; Walsh, D | 1 |
| Crouch, BI; Crouch, DJ; Knick, KA; Matsumura, KS; Rollins, DE | 1 |
| BUCHER, K | 1 |
| HERZOG, H | 1 |
| LANGREHR, D | 1 |
| Dicpinigaitis, PV; Gayle, YE; Gilbert, RD; Solomon, G | 1 |
| Baseluos, C; Cohen, V; Jellinek, SP; Marshall, JP; Stansfield, L; Truong, H | 1 |
| Griffith, JR; Spiller, HA; Winter, ML | 1 |
| Colling, L; Hendershot, AJ; Mauger, TF | 1 |
| Danesh, M; Murase, JE | 1 |
| Evans, MS; Fletcher, AM; Johnson, SR; Maglinger, GB | 1 |
| Beuhler, MC; Bishop-Freeman, SC; Friederich, LW; Shonsey, EM; Winecker, RE | 1 |
| Brown, T; LaRock, R; Lee, S; Mann, P; Mckeon, M; Paranjpe, M; Teo, S | 1 |
| Levi, ME | 1 |
| Bedi, P; Jin, C; Majumder, MR; Sherazi, A; Zahid, E | 1 |
| Leonard, JB; Minhaj, FS | 1 |
| Baumgartner, KT; Filip, AB; Liss, DB; Schwarz, ES; Stephens, RJ | 1 |
| Biehl, A; Cheng, C; Goulding, M; Karami, S; Kim, I; Muñoz, M; Pham, T; Tian, F | 1 |
2 review(s) available for diphenhydramine hydrochloride and benzonatate
| Article | Year |
|---|---|
In brief: benzonatate warning.
Topics: Age Factors; Animals; Antitussive Agents; Arrhythmias, Cardiac; Butylamines; Drug Overdose; Humans; Seizures; United States; United States Food and Drug Administration | 2011 |
A description of the clinical course of severe benzonatate poisonings reported in the literature and to NPDS: A systematic review supplemented with NPDS cases.
Topics: Antitussive Agents; Butylamines; Humans; Poison Control Centers | 2021 |
1 trial(s) available for diphenhydramine hydrochloride and benzonatate
| Article | Year |
|---|---|
Inhibition of cough-reflex sensitivity by benzonatate and guaifenesin in acute viral cough.
Topics: Administration, Inhalation; Administration, Oral; Adult; Antitussive Agents; Butylamines; Capsaicin; Common Cold; Cough; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Guaifenesin; Humans; Male; Middle Aged; Reflex; Sensory System Agents | 2009 |
19 other study(ies) available for diphenhydramine hydrochloride and benzonatate
| Article | Year |
|---|---|
Two fatalities resulting from Tessalon (benzonatate).
Topics: Adolescent; Antitussive Agents; Butylamines; Chromatography, High Pressure Liquid; Female; Humans; Infant; Male; Phenytoin; Spectrophotometry, Ultraviolet; Suicide | 1986 |
Circulatory accessibility of nervous receptors localized in the tracheobronchial tree.
Topics: Animals; Antitussive Agents; Arteries; Biomechanical Phenomena; Bronchi; Butylamines; Dogs; Female; Ligation; Lung; Male; Mechanoreceptors; Pulmonary Circulation; Respiration; Respiration, Artificial; Time Factors; Trachea; Veratridine | 1982 |
Studies on the endoanesthetic effects of lidocaine and benzonatate on non-medullated nerve endings in the left ventricle.
Topics: Animals; Antitussive Agents; Blood Pressure; Butylamines; Cats; Heart Rate; Heart Ventricles; Lidocaine; Mechanoreceptors; Nerve Endings; Reflex | 1981 |
Benzonatate for opioid-resistant cough in advanced cancer.
Topics: Adenocarcinoma; Adult; Aged; Antitussive Agents; Butylamines; Carcinoma, Non-Small-Cell Lung; Colonic Neoplasms; Cough; Drug Resistance; Female; Humans; Lung Neoplasms; Male; Neoplasms, Unknown Primary; Treatment Outcome | 1998 |
Benzonatate overdose associated with seizures and arrhythmias.
Topics: Adult; Antitussive Agents; Arrhythmias, Cardiac; Butylamines; Chromatography, High Pressure Liquid; Drug Overdose; Fatal Outcome; Humans; Infant; Male; Mass Spectrometry; Seizures; Suicide, Attempted | 1998 |
[New effect mechanism of the antitussive drug tessalon].
Topics: Anesthetics; Antitussive Agents; Butylamines; Cough | 1956 |
[Polyethyleneglycol derivatives with antitussive effects, especially tessalon].
Topics: Anesthetics; Antitussive Agents; Butylamines; Cough; para-Aminobenzoates; Polyethylene Glycols | 1956 |
[On the problem of receptor specificity of endoanesthetic effects based on the example of benzononatin (Tessalon)].
Topics: Antitussive Agents; Butylamines; Electrophysiological Phenomena; Electrophysiology; Humans; Sensory Receptor Cells | 1963 |
Cardiac arrest with residual blindness after overdose of Tessalon® (benzonatate) perles.
Topics: Adolescent; Antitussive Agents; Blindness; Butylamines; Drug Overdose; Female; Heart Arrest; Humans; Suicide, Attempted; Treatment Outcome | 2011 |
Benzonatate Ingestion Reported to the National Poison Center Database System (NPDS).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitussive Agents; Arrhythmias, Cardiac; Butylamines; Child; Child, Preschool; Databases, Factual; Female; Humans; Infant; Male; Middle Aged; Poison Control Centers; Poisoning; Retrospective Studies; Survival Rate; United States; Young Adult | 2010 |
Corneal anesthetic abuse from the use of topical benzonatate (Tessalon Perle).
Topics: Administration, Topical; Anesthetics, Local; Antitussive Agents; Butylamines; Cornea; Eye Injuries; Female; Humans; Middle Aged; Visual Acuity | 2011 |
Use of a nonnarcotic antitussive for severe, treatment-resistant oral ulcers.
Topics: Administration, Topical; Antitussive Agents; Butylamines; Chronic Disease; Female; Humans; Male; Oral Ulcer; Pain Measurement; Quality of Life; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2015 |
Benzonatate inhibition of voltage-gated sodium currents.
Topics: Action Potentials; Analysis of Variance; Animals; Antitussive Agents; Biophysical Phenomena; Butylamines; Cell Line, Tumor; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Electric Stimulation; Mice; NAV1.7 Voltage-Gated Sodium Channel; Neuroblastoma; Patch-Clamp Techniques; Sodium Channel Blockers; Time Factors | 2016 |
Benzonatate Toxicity: Nothing to Cough At.
Topics: Antitussive Agents; Butylamines; Clinical Decision-Making; Consumer Product Safety; Cough; Dose-Response Relationship, Drug; Drug Overdose; Humans; Nonprescription Drugs; Patient Safety; Risk Assessment; Risk Factors | 2017 |
The Antitussive Benzonatate Is Not Tumorigenic in Rodent Carcinogenicity Studies.
Topics: Administration, Oral; Animals; Antitussive Agents; Butylamines; Carcinogenicity Tests; Dose-Response Relationship, Drug; Female; Genes, ras; Male; Maximum Tolerated Dose; Mice, Transgenic; Neoplasms, Experimental; Rats, Wistar | 2018 |
Primary Care Management of Upper Respiratory Infections in the Women's Health Care Setting.
Topics: Adult; Ambulatory Care; Antitussive Agents; Butylamines; Coinfection; Diagnosis, Differential; Disease Management; Female; Humans; Midwifery; Physical Examination; Primary Health Care; Respiratory Tract Infections; Women's Health | 2019 |
Cardiac Arrest Due to Benzonatate Overdose.
Topics: Acidosis; Adult; Antitussive Agents; Butylamines; Drug Overdose; Female; Heart Arrest; Humans | 2019 |
Benzonatate Overdose Presenting as Cardiac Arrest with Rapidly Narrowing QRS Interval.
Topics: Adolescent; Anesthetics, Local; Antitussive Agents; Arrhythmias, Cardiac; Butylamines; Child; Drug Overdose; Epinephrine; Female; Heart Arrest; Humans; Naloxone; Sodium Channels | 2022 |
Benzonatate Exposure Trends and Adverse Events.
Topics: Adolescent; Antitussive Agents; Butylamines; Child; Child, Preschool; Humans; Infant; Infant, Newborn; Poison Control Centers; Retrospective Studies; United States | 2022 |